Liver steatosis or non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries. However, the cause and treatments are still controversial. Nitric oxide (NO) and its derivatives play important roles in the physiology and pathophysiology of the vascular system and liver metabolism. We quantified intraperitoneal fat and liver fat-fraction using 3T MRI in eNOS-/- mice fed with HFD and investigated (1) whether pharmacological treatments for type 2 diabetes and hypertension reduced fat deposition and (2) if the phenotype could be recapitulated by administration of an inhibitor of endothelial NO synthesis (L-NAME) in wild type mice.
This abstract and the presentation materials are available to members only; a login is required.